4th Apr 2011 17:05
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the directors' interests in the Ordinary shares and American Depository Shares (ADSs) of GlaxoSmithKline plc.
On 31 March 2011, the Company's Non-Executive Directors were provisionally allocated awards over Ordinary shares at a price of £11.90 per Ordinary share and $38.34 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 January 2011 to 31 March 2011:
Non Executive Director | Ordinary Shares | American Depository Shares (ADSs) |
Sir Christopher Gent | 2836.13 | |
Prof. Sir Roy Anderson | 866.60 | |
Dr Stephanie Burns | 540.82 | |
Mr Lawrence Culp | 1081.63 | |
Sir Crispin Davis | 3256.30 | |
Sir Deryck Maughan | 772.59 | |
Mr James Murdoch | 2836.13 | |
Dr Daniel Podolsky | 1043.00 | |
Mr Tom de Swaan | 1129.20 | |
Sir Robert Wilson | 866.60 |
The Company and the Non-Executive Directors were informed of these allocations on 1 April 2011.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
4 April 2011
Related Shares:
Glaxosmithkline